Finance

Lists
EMCURE:NSE
Emcure Pharmaceuticals Ltd
1 767,70 ₹
-0,15%
(-2,70) 1D
26 հոկ, 14:10:19 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMCURE...
Open
1 773,20 ₹
High
1 786,70 ₹
Low
1 751,00 ₹
Mkt. cap
335,94 մլրդ
Avg. vol.
170,33 հզր
Volume
99,50 հզր
Dividend
0,20%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
33,13
52-wk high
2 100,70 ₹
52-wk low
1 306,50 ₹
EPS
53,35 ₹
No. of employees
7 հզր
Open
1 773,20 ₹
High
1 786,70 ₹
Low
1 751,00 ₹
Mkt. cap
335,94 մլրդ
Avg. vol.
170,33 հզր
Volume
99,50 հզր
Dividend
0,20%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
33,13
52-wk high
2 100,70 ₹
52-wk low
1 306,50 ₹
EPS
53,35 ₹
No. of employees
7 հզր
News stories
From web sources and news partners
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 հզր
Founded16 ապր, 1981 թ.
Headquarters-
Sector-
Websiteemcure.com
Next call 8 օրից
նոյ 3, երք, 12:30
Fiscal period
Q2 2027
- / 14,90 ₹
Revenue / Est. (INR)
- / 26,52 մլրդ
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
22,70 մլրդ
23,63 մլրդ
24,70 մլրդ
25,80 մլրդ
Cost of goods sold
8,90 մլրդ
9,62 մլրդ
10,93 մլրդ
10,73 մլրդ
Cost of revenue
8,90 մլրդ
9,62 մլրդ
10,93 մլրդ
10,73 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,85 մլրդ
3,87 մլրդ
7,21 մլրդ
4,09 մլրդ
Operating expense
10,46 մլրդ
10,46 մլրդ
9,97 մլրդ
11,09 մլրդ
Total operating expenses
19,35 մլրդ
20,08 մլրդ
20,90 մլրդ
21,82 մլրդ
Operating income
3,34 մլրդ
3,55 մլրդ
3,79 մլրդ
3,98 մլրդ
Other non operating income
31,23 մլն
18,53 մլն
-363,67 մլն
20,71 մլն
EBT including unusual items
3,41 մլրդ
3,14 մլրդ
3,41 մլրդ
3,94 մլրդ
EBT excluding unusual items
3,41 մլրդ
3,52 մլրդ
3,72 մլրդ
3,92 մլրդ
Income tax expense
900,47 մլն
824,22 մլն
974,40 մլն
1,01 մլրդ
Effective tax rate
26,37%
26,27%
28,56%
25,67%
Other operating expenses
5,57 մլրդ
5,54 մլրդ
1,70 մլրդ
5,90 մլրդ
Net income
2,43 մլրդ
2,31 մլրդ
2,43 մլրդ
2,94 մլրդ
Net profit margin
10,73%
9,75%
9,86%
11,39%
Earnings per share
12,85
13,67
14,70
15,34
Interest and investment income
-
-
16,83 մլն
-
Interest expense
-325,42 մլն
-379,75 մլն
-92,49 մլն
-315,36 մլն
Net interest expenses
-325,42 մլն
-379,75 մլն
-75,66 մլն
-315,36 մլն
Depreciation and amortization charges
1,05 մլրդ
1,05 մլրդ
1,06 մլրդ
1,10 մլրդ
EBITDA
4,37 մլրդ
4,37 մլրդ
4,67 մլրդ
5,02 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps